FIGURE 3.
Kaplan-Meier survival estimates of the cumulative probability of visual field progression. The numbers of subjects with Guided Progression Analysis progression were 1 and 7 in the brimonidine and timolol groups, respectively. This is a statistically significant result according to the log-rank test (P=0.0198).